Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.85M Sell
100,732
-474,983
-83% -$6.79M 0.01% 851
2026
Q1
$9.32M Sell
575,715
-915,252
-61% -$10.8M 0.07% 250
2025
Q4
$5.55M Buy
+1,490,967
New +$4.19M 0.04% 438
2024
Q3
Sell
-1,185,758
Closed -$2.8M 1744
2024
Q2
$2.8M Buy
1,185,758
+936,240
+375% +$2.02M 0.02% 657
2024
Q1
$514K Buy
+249,518
New +$499K ﹤0.01% 1131
2023
Q4
Sell
-120,892
Closed -$238K 1628
2023
Q3
$238K Buy
120,892
+34,406
+40% +$88.1K ﹤0.01% 1478
2023
Q2
$239K Buy
+86,486
New +$246K ﹤0.01% 1630

Other funds holding ERAS

Michael Gelband's ERAS Position: Q2 2026 in Review

Michael Gelband reduced its Erasca (ERAS) stake by 83% in Q2 2026, selling an estimated $6.79M and leaving 100,732 shares worth $1.85M. The position accounts for 0.01% of the portfolio, ranked #851.

Michael Gelband first reported a position in ERAS in Q2 2023 and has held it in 7 quarters since. The position peaked at $9.32M in Q1 2026. 255 funds tracked by Wall St. Rank hold ERAS as of Q2 2026.

  • Michael Gelband held 100,732 shares of Erasca worth $1.85M as of Q2 2026.
  • Michael Gelband sold 474,983 Erasca shares in Q2 2026, an estimated $6.79M.
  • Erasca made up 0.01% of Michael Gelband's portfolio in Q2 2026, its #851 holding.
  • Michael Gelband first reported a position in Erasca in Q2 2023 and has held it in 7 quarters since.
  • Michael Gelband's Erasca position peaked at $9.32M in Q1 2026.
  • 255 funds tracked by Wall St. Rank held Erasca as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.